Resona Asset Management Co. Ltd. Has $4 Million Stock Position in Astera Labs, Inc. $ALAB

Resona Asset Management Co. Ltd. reduced its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 4.5% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,973 shares of the company’s stock after selling 1,755 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Astera Labs were worth $4,002,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Reflection Asset Management bought a new stake in shares of Astera Labs in the fourth quarter worth $25,000. Smartleaf Asset Management LLC grew its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares in the last quarter. Hilltop National Bank increased its stake in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the last quarter. Aventura Private Wealth LLC acquired a new stake in Astera Labs in the 4th quarter valued at $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in Astera Labs during the 4th quarter worth about $33,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the sale, the director directly owned 57,466 shares of the company’s stock, valued at approximately $25,859,700. The trade was a 5.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,040,691 shares of company stock valued at $507,675,380. 10.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on ALAB. UBS Group raised their price objective on Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a report on Monday, June 29th. Barclays upped their target price on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Royal Bank Of Canada increased their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Bank of America raised their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Finally, Rothschild & Co Redburn began coverage on Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $265.75.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $412.97 on Monday. Astera Labs, Inc. has a 12-month low of $88.18 and a 12-month high of $499.48. The business has a 50 day moving average of $335.76 and a 200-day moving average of $214.94. The stock has a market cap of $70.79 billion, a PE ratio of 279.03, a P/E/G ratio of 4.65 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period last year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts expect that Astera Labs, Inc. will post 1.88 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.